GLT8D1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.609200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.728800E-01
Normal-vs-Stage2
8.328800E-01
Normal-vs-Stage3
7.299600E-01
Normal-vs-Stage4
6.723200E-01
Stage1-vs-Stage2
5.396600E-01
Stage1-vs-Stage3
5.368000E-01
Stage1-vs-Stage4
6.833400E-01
Stage2-vs-Stage3
5.391000E-01
Stage2-vs-Stage4
2.505400E-01
Stage3-vs-Stage4
4.548600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.969000E-01
Normal-vs-AfricanAmerican
6.256800E-01
Normal-vs-Asian
5.391200E-01
Caucasian-vs-AfricanAmerican
4.407800E-01
Caucasian-vs-Asian
2.943400E-01
AfricanAmerican-vs-Asian
9.926800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.614000E-01
Normal-vs-Female
9.693800E-01
Male-vs-Female
9.547800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.631000E-01
Normal-vs-Age(41-60Yrs)
7.345000E-01
Normal-vs-Age(61-80Yrs)
8.609800E-01
Normal-vs-Age(81-100Yrs)
6.173400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.560400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.401000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.128000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.888400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.864300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.515800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.419800E-01
Normal-vs-Daily Drinker
5.545200E-01
Normal-vs-Weekly Drinker
8.980400E-01
Normal-vs-Occasional Drinker
6.963600E-01
Normal-vs-Social Drinker
8.156000E-01
Non Drinker-vs-Daily Drinker
5.788200E-01
Non Drinker-vs-Weekly Drinker
2.281800E-01
Non Drinker-vs-Occasional Drinker
2.523900E-02
Non Drinker-vs-Social Drinker
5.723800E-02
Daily Drinker-vs-Weekly Drinker
4.326000E-01
Daily Drinker-vs-Occasional Drinker
9.367800E-02
Daily Drinker-vs-Social Drinker
1.348170E-01
Weekly Drinker-vs-Occasional Drinker
3.425200E-01
Weekly Drinker-vs-Social Drinker
5.242800E-01
Occasional Drinker-vs-Social Drinker
6.846200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.164600E-01
Normal-vs-Grade 2
5.632200E-01
Normal-vs-Grade 3
1.315840E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.104800E-01
Grade 1-vs-Grade 3
9.924600E-01
Grade 1-vs-Grade 4
3.164600E-01
Grade 2-vs-Grade 3
8.545200E-01
Grade 2-vs-Grade 4
5.632200E-01
Grade 3-vs-Grade 4
1.315840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.547600E-01
Normal-vs-NonDiabetic
9.603400E-01
Diabetic-vs-NonDiabetic
2.336200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.562400E-01
Normal-vs-NoPancreatitis
9.309000E-01
Pancreatitis-vs-NoPancreatitis
7.171400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.546600E-01
Normal-vs-N1
8.374000E-01
N0-vs-N1
2.308400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.280400E-01
Normal-vs-TP53-NonMutant
9.248600E-01
TP53-Mutant-vs-TP53-NonMutant
9.218400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
